Cronos Group stock slips 1.12% and underperforms market

13 articles · Updated · MarketWatch · May 1

The shares closed at $2.64 as the Nasdaq rose 0.89% to 25,114.44 and the Dow fell 0.31% to 49,499.27 in a mixed Friday session.
Cronos ended 23.03% below its 52-week high of $3.43, reached on 15 December.
Trading volume was 863,419 shares, 590,952 below the stock's 50-day average of 1.5 million, indicating lighter-than-usual activity.

Cronos boasts record revenue and zero debt, so why does its stock price still lag well below its yearly high?

With medical cannabis rescheduled in the US, what does this mean for Cronos's path to profitability and American market entry?

As US cannabis reform unfolds, is Cronos's aggressive expansion into Europe and Israel the smarter long-term play?